Page last updated: 2024-08-25

narciclasine and Malignant Melanoma

narciclasine has been researched along with Malignant Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, JP; Berger, W; Evidente, A; Hutton, J; Kinzy, TG; Kiss, R; Kornienko, A; Lallemand, B; Lefranc, F; Mathieu, V; Pelletier, J; Pirker, C; Prévost, M; Robert, F; Van Antwerpen, P; Van Goietsenoven, G; Vandenbussche, G1
Evidente, A; Kiss, R; Kornienko, A; Lefranc, F; Mathieu, V; Van Goietsenoven, G1

Reviews

1 review(s) available for narciclasine and Malignant Melanoma

ArticleYear
Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers.
    Medicinal research reviews, 2013, Volume: 33, Issue:2

    Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Brain Neoplasms; Cohort Studies; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Glioblastoma; GTP Phosphohydrolases; Humans; In Vitro Techniques; Melanoma; Mice; Molecular Targeted Therapy; Neoplasms; Phenanthridines; Structure-Activity Relationship; Transplantation, Heterologous; Treatment Outcome

2013

Other Studies

1 other study(ies) available for narciclasine and Malignant Melanoma

ArticleYear
Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010, Volume: 24, Issue:11

    Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line, Tumor; Cytoskeleton; Drug Delivery Systems; Gene Expression Regulation; Humans; Hydroxyquinolines; Liliaceae; Melanoma; Mice; Models, Molecular; Peptide Elongation Factor 1; Phenanthridines; Quinolones; Saccharomyces cerevisiae

2010